🔎 Trials Near Me

Početna › Depresija › Florida › Orlando

Kliničke studije za Depresija u gradu Orlando, FL

17 studija za Depresija traži sudionike na lokacijama u gradu Orlando i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

U tijeku regrutacijaFaza 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

U tijeku regrutacijaFaza 3
  • Accel Research Sites - Maitland, Maitland · 6 mi udaljenosti
Od 18 do 85 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

U tijeku regrutacijaFaza 2
  • Seaport Investigator Site, Orlando
Od 18 do 65 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07065240

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

U tijeku regrutacijaFaza 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

U tijeku regrutacijaFaza 2
  • Draig Clinical Site, Orlando
Od 18 do 75 godina · Oba spola · Ažurirano 26. kol 2026. · NCT07300969

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

U tijeku regrutacijaFaza 3
  • Neurocrine Clinical Site, Maitland · 6 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 10. kol 2026. · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

U tijeku regrutacijaFaza 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi udaljenosti
Od 18 do 75 godina · Oba spola · Ažurirano 6. kol 2026. · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

U tijeku regrutacijaFaza 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Od 18 do 74 godina · Oba spola · Ažurirano 3. kol 2026. · NCT06775379

Adapting Single Sessions Interventions for Type 1 Diabetes

U tijeku regrutacija
  • Nemours Children's Hospital - FL, Orlando
Od 12 do 17 godina · Oba spola · Ažurirano 24. srp 2026. · NCT06752369

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

U tijeku regrutacijaFaza 3
  • Neurocrine Clinical Site, Maitland · 6 mi udaljenosti
  • Neurocrine Clinical Site, Maitland · 6 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT06966401

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

U tijeku regrutacijaOpažajna studija
  • Nemours Foundation, Orlando
18 Months – 11 Years · Oba spola · Ažurirano 6. srp 2026. · NCT07048574

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

U tijeku regrutacija
  • Luxury Psychiatry Clinic, Winter Garden · 13 mi udaljenosti
Od 40 godina i više · Žene · Ažurirano 17. velj 2026. · NCT07413705

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

U tijeku regrutacijaFaza 3
  • Neurocrine Clinical Site, Maitland · 6 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 29. lis 2025. · NCT06786624

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

U tijeku regrutacijaFaza 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Od 18 do 65 godina · Oba spola · Ažurirano 23. sij 2025. · NCT06223880

The Lake Nona Life Project

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Lake Nona Institute, Orlando
Od 18 do 110 godina · Oba spola · Ažurirano 6. pro 2024. · NCT02533804

Studije za Depresija u drugim gradovima

Ostale studije u gradu Orlando

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.